Log in

OTCMKTS:ERBAERBA Diagnostics Stock Price, Forecast & News

$0.18
0.00 (0.00 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.18
Now: $0.18
$0.18
50-Day Range
$0.14
MA: $0.16
$0.19
52-Week Range
$0.06
Now: $0.18
$0.31
Volume6 shs
Average Volume3,467 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1.3
ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ERBA
Previous SymbolNYSEMKT:ERB
CUSIPN/A
Phone305-324-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ERBA News and Ratings via Email

Sign-up to receive the latest news and ratings for ERBA and its competitors with MarketBeat's FREE daily newsletter.

ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions

How has ERBA Diagnostics' stock been impacted by COVID-19 (Coronavirus)?

ERBA Diagnostics' stock was trading at $0.28 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ERBA shares have decreased by 35.7% and is now trading at $0.18. View which stocks have been most impacted by Coronavirus.

Has ERBA Diagnostics been receiving favorable news coverage?

Press coverage about ERBA stock has trended very negative on Monday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ERBA Diagnostics earned a media sentiment score of -3.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutERBA Diagnostics.

Who are some of ERBA Diagnostics' key competitors?

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ERBA Diagnostics investors own include Ekf Diagnostics (EKF), Synergy Pharmaceuticals (SGYP), Attunity (ATTU), Auxly Cannabis Group (CBWTF), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), IQIYI (IQ), Myriad Genetics (MYGN) and Nektar Therapeutics (NKTR).

Who are ERBA Diagnostics' key executives?

ERBA Diagnostics' management team includes the following people:
  • Mr. Suresh Vazirani, Exec. Chairman & MD (Age 69)
  • Mr. David Barka, Interim Chief Exec. Officer (Age 38)
  • Mr. Nate Wells, Chief Financial Officer
  • Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.

What is ERBA Diagnostics' stock symbol?

ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."

How do I buy shares of ERBA Diagnostics?

Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ERBA Diagnostics' stock price today?

One share of ERBA stock can currently be purchased for approximately $0.18.

What is ERBA Diagnostics' official website?

The official website for ERBA Diagnostics is www.erbadiagnostics.com.

How can I contact ERBA Diagnostics?

ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.